Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A low grade, late-metastasizing variant of fibrosarcoma characterized by alternating fibrous and myxoid areas and a whorling growth pattern. The neoplastic cells have a spindle morphology, and lack hyperchromasia or significant nuclear atypia. Approximately 40% of cases show the focal presence of collagen rosettes. A t(7;16)(q33;p11) translocation has been identified in the majority of cases, associated with the presence of FUS-CREB3L2 fusion protein. Rare cases carry the t(11;16)(p11;p11) translocation which is associated with the presence of the FUS-CREB3L1 fusion protein.
Biomarker and diagnostic research for low grade fibromyxoid sarcoma has been reported in the published literature.
4 clinical trials registered, 3 recruiting. Interventions under study include drug therapy, other interventions, and procedural interventions. Pipeline includes 2 PHASE2, 1 PHASE1, 1 NA. Research is primarily sponsored by academic and government institutions.
39 publications have been identified in PubMed for low grade fibromyxoid sarcoma. Research spans Case Report / Case Series (56%), Diagnostic / Biomarker (21%), and Basic Science / Preclinical (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 22 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 4:31 PM UTC
56%
Testing and diagnosis research | 8 | 21% |
Laboratory research | 4 | 10% |
Research summaries | 3 | 8% |
Disease patterns and progression | 2 | 5% |
Yoshida A (2026). [PMID: 42133362](https://pubmed.ncbi.nlm.nih.gov/42133362/). *Am J Surg Pathol*. [Basic Science / Preclinical]
Nahal A (2026). [PMID: 42100950](https://pubmed.ncbi.nlm.nih.gov/42100950/). *Int J Surg Pathol*. [Diagnostic / Biomarker]
Kar BK (2026). [PMID: 42028589](https://pubmed.ncbi.nlm.nih.gov/42028589/). *J Clin Orthop Trauma*. [Case Report / Case Series]
Burkitbayev Z (2026). [PMID: 41768229](https://pubmed.ncbi.nlm.nih.gov/41768229/). *Frontiers in oncology*. [Case Report / Case Series]
Aggarwal G (2026). [PMID: 41870314](https://pubmed.ncbi.nlm.nih.gov/41870314/). *International journal of surgical pathology*. [Review / Meta-Analysis]
Krebbekx GGJ (2026). [PMID: 41681837](https://pubmed.ncbi.nlm.nih.gov/41681837/). *Cancers*. [Case Report / Case Series]
Bestman EG (2026). [PMID: 41615547](https://pubmed.ncbi.nlm.nih.gov/41615547/). *Head and neck pathology*. [Case Report / Case Series]
Zhao X (2026). [PMID: 42070221](https://pubmed.ncbi.nlm.nih.gov/42070221/). *J Ultrasound*. [Case Report / Case Series]
Petridou M (2026). [PMID: 41978874](https://pubmed.ncbi.nlm.nih.gov/41978874/). *Maedica (Bucur)*. [Case Report / Case Series]
Malik F (2026). [PMID: 41775633](https://pubmed.ncbi.nlm.nih.gov/41775633/). *The American journal of surgical pathology*. [Basic Science / Preclinical]
AI-curated news mentioning low grade fibromyxoid sarcoma
Updated Jul 25, 2026
A recent study analyzed 26 cases of low-grade fibromyxoid sarcoma located in the abdominopelvic and retroperitoneal regions, contributing valuable insights into its clinicopathologic characteristics. This research adds to the existing literature on this rare sarcoma subtype.